Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - nature.com
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone marrow …, 2008 - pubmed.ncbi.nlm.nih.gov
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

[引用][C] Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short …

A AL BEIHANY, H AL OMAR… - Bone marrow …, 2008 - pascal-francis.inist.fr
Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic
hematopoietic stem cell transplantation by early administration of a short course of …

[PDF][PDF] Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - academia.edu
Hepatic veno-occlusive disease (VOD) is a clinical syndrome characterized by painful
hepatomegaly, jaundice, ascites and fluid retention manifested by otherwise unexplained …

[PDF][PDF] Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - researchgate.net
Hepatic veno-occlusive disease (VOD) is a clinical syndrome characterized by painful
hepatomegaly, jaundice, ascites and fluid retention manifested by otherwise unexplained …

Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - search.ebscohost.com
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - go.gale.com
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2007 - europepmc.org
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

[引用][C] Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short …

AL BEIHANY - Bone Marrow Transplant, 2008 - cir.nii.ac.jp
Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic
hematopoietic stem cell transplantation by early administration of a short course of …

Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course …

A Al Beihany, H Al Omar, E Sahovic… - Bone Marrow …, 2008 - search.ebscohost.com
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …